IONS FDA decision — Mar 30, 2026
✓ APPROVED
Ionis Pharmaceuticals Inc. — SPINRAZA (Nusinersen) - (DEVOTE) · Spinal muscular atrophy (SMA).
Run-up into the decision (T-120 → T+5) PDUFA 3/30/26 $86.5 $68.94 10/13/25 Daily close, T-120 (10/13/25) through T+5. Run-up high $86.5 on 2/9/26, low $68.94 on 10/14/25 (T-120 to T-1). FDA decision 3/30/26. Historical price action, not a forecast.
Key facts
FDA decision date 2026-03-30
Outcome Approved
Drug / candidate SPINRAZA (Nusinersen) - (DEVOTE)
Company Ionis Pharmaceuticals Inc.
120-day run-up (T-120→T-1) +4.5%
Not affiliated with or endorsed by the FDA. Informational and educational only — not investment advice. Verify against primary FDA / SEC / company filings. © 2026 pdufa.bio